PPJ Healthcare Enterprises(PPJE)
$0.000.00 (0.00%)
PPJE
PPJ Healthcare Enterprises financials statements
$0.00
At close:0.00 (0.00%)
PPJ Healthcare Enterprises (PPJE) Ratios
52 Followers
PPJ Healthcare Enterprises Ratios
PPJE's free cash flow for Q1 2025 was $2.19M. For the 2025 fiscal year, PPJE's free cash flow was decreased by $-4.00 and operating cash flow was $2.19M. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.53 | 2.56 | 2.70 | 2.63 | 1.92 |
| Quick Ratio | 2.52 | 2.56 | 2.69 | 2.62 | 1.91 |
| Cash Ratio | 0.00 | 0.01 | 0.06 | 0.11 | 0.01 |
| Solvency Ratio | 0.00 | 0.03 | 0.06 | 0.06 | 0.04 |
| Operating Cash Flow Ratio | 0.32 | 0.36 | 0.46 | 2.25 | 1.92 |
| Short-Term Operating Cash Flow Coverage | 0.93 | 0.98 | 1.13 | 5.31 | 5.91 |
| Net Current Asset Value | $ 11.58M | $ 11.00M | $ 11.17M | $ 10.00M | $ 6.34M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.14 | 0.14 | 0.15 | 0.16 |
| Debt-to-Equity Ratio | 0.21 | 0.22 | 0.22 | 0.24 | 0.31 |
| Debt-to-Capital Ratio | 0.17 | 0.18 | 0.18 | 0.19 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.60 | 1.59 | 1.54 | 1.56 | 1.95 |
| Debt Service Coverage Ratio | 0.00 | 0.03 | 0.14 | 0.06 | 0.11 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 284.02 | 1.57 | 1.26 | 0.67 | 0.77 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 320.40 | 34.04 | 6.13 | 13.66 | 8.91 |
| Profitability Margins | |||||
| Gross Profit Margin | 15.56% | 30.39% | 38.06% | 43.13% | 33.31% |
| EBIT Margin | 1.22% | 10.51% | 17.85% | 22.13% | 13.15% |
| EBITDA Margin | 1.22% | 10.51% | 46.76% | 22.13% | 80.67% |
| Operating Profit Margin | 1.22% | 10.51% | 17.85% | 22.13% | 13.15% |
| Pretax Profit Margin | 1.22% | 10.51% | 17.85% | 21.76% | 13.15% |
| Net Profit Margin | 1.22% | 10.51% | 17.85% | 21.76% | 13.15% |
| Continuous Operations Profit Margin | 1.22% | 10.51% | 17.85% | 21.76% | 13.15% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 100.00% | 100.00% | 100.00% | 98.31% | 100.00% |
| Return on Assets (ROA) | 0.04% | 0.39% | 0.75% | 0.82% | 0.28% |
| Return on Equity (ROE) | 0.06% | 0.62% | 1.16% | 1.28% | 0.55% |
| Return on Capital Employed (ROCE) | 0.06% | 0.62% | 1.16% | 1.31% | 0.55% |
| Return on Invested Capital (ROIC) | 0.05% | 0.51% | 0.95% | 1.06% | 0.42% |
| Return on Tangible Assets | 0.04% | 0.41% | 0.79% | 0.82% | 0.30% |
| Earnings Yield | 88.01% | 4.52% | 6.65% | 3.64% | 1.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.28 | 0.30 | 0.28 | 0.28 | 0.25 |
| Payables Turnover | 3.96 | 17.66 | 21.74 | 45.52 | 6.53 |
| Inventory Turnover | 138.76 | 55.61 | 14.92 | 7.92 | 9.04 |
| Fixed Asset Turnover | 43.54 | 39.79 | 14.66 | 14.45 | 13.61 |
| Asset Turnover | 0.03 | 0.04 | 0.04 | 0.04 | 0.02 |
| Working Capital Turnover Ratio | 0.06 | 0.06 | 0.07 | 0.08 | 0.05 |
| Cash Conversion Cycle | 1236.68 | 1212.76 | 1313.88 | 1338.01 | 1440.23 |
| Days of Sales Outstanding | 1326.28 | 1226.87 | 1306.20 | 1299.97 | 1455.80 |
| Days of Inventory Outstanding | 2.63 | 6.56 | 24.46 | 46.06 | 40.36 |
| Days of Payables Outstanding | 92.23 | 20.67 | 16.79 | 8.02 | 55.94 |
| Operating Cycle | 1328.91 | 1233.43 | 1330.67 | 1346.03 | 1496.16 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 3461538.50 | 4408854.33 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 3461538.50 | 4408854.33 |
| Operating Cash Flow Coverage Ratio | 0.93 | 0.98 | 1.13 | 5.31 | 5.91 |
| Operating Cash Flow to Sales Ratio | 3.67 | 3.56 | 3.82 | 21.34 | 43.29 |
| Free Cash Flow Yield | 26528.16% | 153.35% | 142.30% | 357.54% | 455.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 1.14 | 22.10 | 15.04 | 27.44 | 72.32 |
| Price-to-Sales (P/S) Ratio | 0.01 | 2.32 | 2.68 | 5.97 | 9.51 |
| Price-to-Book (P/B) Ratio | 0.00 | 0.14 | 0.17 | 0.35 | 0.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.65 | 0.70 | 0.28 | 0.22 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.65 | 0.70 | 0.28 | 0.22 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | 321.53 | 56.14 | 11.87 | 40.64 | 20.70 |
| Enterprise Value | 2.60M | 4.20M | 4.39M | 5.83M | 5.10M |
| EV to EBITDA | 321.53 | 56.14 | 11.87 | 40.64 | 20.70 |
| EV to Sales | 3.91 | 5.90 | 5.55 | 8.99 | 16.70 |
| EV to Free Cash Flow | 1.07 | 1.66 | 1.45 | 0.42 | 0.39 |
| EV to Operating Cash Flow | 1.07 | 1.66 | 1.45 | 0.42 | 0.39 |
| Tangible Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholders’ Equity Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 0.98 | 1.00 |
| Research & Development to Revenue | 0.13 | 0.00 | 0.03 | 0.02 | 0.00 |
| SG&A to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 301.42 | 33.89 | 21.40 | 98.10 | 329.35 |
Currency in USD

